CO96 Myelofibrosis Symptom Assessment Form Total Symptom Score (MFSAF TSS) v4.0: Measurement Properties from the Momentum Phase 3 Study
Daskalopoulou, C., Gorsh, B., Dumi, G., Deheshi, S., Gwaltney, C., von Maltzahn, R., Paty, J., Ellis, C., Kawashima, J., Klencke, B.J., Mesa, R.
Published in Value in health (01.12.2023)
Published in Value in health (01.12.2023)
Get full text
Journal Article
PCN19 Beyond a Binary Endpoint: Longitudinal and Individual Symptom Analyses from the Simplify-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in JAK Inhibitor Naive Myelofibrosis Patients
Mesa, R., Hudgens, S., Floden, L., Palmer, J., Gupta, V., McLornan, D.P., McMullin, M.F., Kiladjian, J.J., Foltz, L., Platzbecker, U., Fox, M.L., Mead, A.J., Ross, D.M., Oh, S.T., Perkins, A., Leahy, M.F., Deheshi, S., Donahue, R., Klencke, B.J., Verstovsek, S.
Published in Value in health (01.06.2021)
Published in Value in health (01.06.2021)
Get full text
Journal Article